ISTH DIC Subcommittee Communication on Anticoagulation In COVID-19
Although the current evidence is still insufficient, we provide a pragmatic approach to anticoagulation in COVID‐19, but stress the need for further trials in this area.
You may also like
Biocompatibility of a Polymer-Coated Membrane Possessing a Hydrophilic Blood-Contacting Layer: Adsorption-Related Assessment
Thus, acrylate-based copolymer coating could inhibit the adsorption of various peptide compounds.
1 min read
Use of Recombinant Activated Factor VII for Bleeding Following Operations Requiring Cardiopulmonary Bypass
Therapy with recombinant activated factor VII (rFVIIa) may be an effective treatment strategy for patients with refractory bleeding.
1 min read